Transforming Diagnostics with AI
MyeloAID brings AI to the morphological differentiation of bone marrow smears. It counts and classifies the cells and produces a detailed, reproducible myelogram in minutes. And it works with the microscope or scanner you already have, so there’s no six-figure appliance to buy.
A first step toward faster, more consistent diagnosis across hematology.
Our Vision
Raising the standard of diagnosis in hematology
MyeloAID is our starting point, not the whole ambition. Reading bone marrow morphology by hand is slow, labour-intensive, and varies from one reader to the next. It depends on a shrinking pool of trained specialists.
By handing the high-volume counting to AI, we aim for analysis that is:
- Faster and more consistent, with less inter- and intra-reader variability.
- Accessible to more labs, not only specialised centres.
- A path to better, timelier decisions for patients with blood disorders, wherever they are diagnosed.
Our edge
Built on the right expertise and the right data
Built by the people who do the work
MyeloAID is made by hematologists and MTAs for hematologists and MTAs. The people who read bone marrow every day shape how the software behaves, so it fits how labs actually work instead of forcing a new routine.
A data advantage that is hard to copy
Our models learn from curated, proprietary datasets of both healthy and diseased bone marrow, sourced from leading European hematology centres and labelled by more than ten of the field’s top morphology experts.
Partners
Trusted by leading clinics, labs, and research partners
